市場調查報告書
商品編碼
1308742
2030 年益生元市場預測 - 按成分、疾病類型、人口統計、最終用戶和地區進行的全球分析Prebiotics Market Forecasts to 2030 - Global Analysis By Ingredients (Fructo-oligosaccharide, Inulin, Galacto-oligosaccharides and Other Ingredients), Disease Type, Demography, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球益生元市場規模將達到 82 億美元,預測期內復合年增長率為 16.9%,預計到 2030 年將達到 246 億美元。
益生元是不可消化的可溶性纖維,有助於結腸中有益細菌的生長。 益生元具有許多健康益處,包括改善人體免疫功能、消化功能以及控制血糖和膽固醇水平。 蘆筍、菊苣根、大蒜和洋蔥富含益生元。 益生元有多種用途,例如改善食品和飲料的質地或在不添加糖的情況下使其變甜。 此外,益生元還可以增加產奶量並幫助奶牛生長。
根據國家乳製品發展委員會 (NDDB) 的數據,到 2030 年,印度對乳製品的需求預計將達到 2.665 億噸。
由於腸道健康益生元的消費量增加,益生元市場的收入正在增長。 益生元原材料被用於許多最終用途行業來製造糖替代品和低熱量食品。 低聚果糖菊粉、低聚甘露聚醣 (MOS) 和低聚半乳糖 (GOS) 廣泛應用於食品和飲料行業,對消化系統溫和,促進腸道內有益細菌的生長,改善腸道健康。 益生元就像肥料一樣,促進腸道內有益細菌的生長。 它存在於許多水果和蔬菜中,特別是那些含有膳食纖維和抗性澱粉的水果和蔬菜,它們是一種複雜的碳水化合物。
消費者對益生元產品的健康益處的認識不斷下降,限制了市場的收入增長。 食品和飲料行業益生元產品的選擇有限,部分原因是缺乏對食品和飲料產品中益生元成分的一般了解。 此外,消費者對益生元產品的好處的無知和缺乏有效的營銷策略都限制了市場的增長。
隨著消費者對含有較少糖和脂肪而不影響味道和質地的食品和飲料產品的需求,益生元和其他植物性低聚醣預計將越來越受歡迎。 隨著肥胖率上升,市場預計將進一步擴大。 由於益生元能夠促進益生菌和其他結腸細菌的生長並增強胃腸道和免疫系統功能,預計在預測期內對益生元的需求也會增加。
阻礙全球益生元市場增長的一個重要因素是過量服用益生元引起的腹瀉、胃食管反流和腹痛等副作用。 預計在預測期內阻礙該市場增長的另一個因素是原材料價格的波動。
在新冠肺炎 (COVID-19) 疫情期間,對益生元補充劑的需求有所增加,因為消費者更喜歡增強免疫系統的補充劑。 食品、飲料和乳製品在任何商店都很容易買到,因此隔離期間需求很高。 然而,由於分銷網絡中斷,益生元的銷售陷入困境。
在預測期內,食品和飲料領域佔據最大份額。 該細分市場的巨大市場份額主要歸因於消費者健康意識的增強以及對益生元食品添加劑的需求增加。 此外,該細分市場的增長還受到人們引領健康和積極生活方式的趨勢、食品和飲料行業新產品開發投資的增加以及對健康益處的認識的推動。
由於低聚半乳糖 (GOS) 的使用量不斷增加,預計該細分市場在不久的將來將具有巨大的增長潛力。 此外,它還具有許多健康益處,包括通過促進鈣吸收改善骨礦化、預防結腸癌、雙歧桿菌生長和替代母乳低聚醣。
亞太地區的益生元市場份額最高。 影響亞太市場發展的主要因素之一是該地區知名領導者的存在。 由於該地區龐大的人口和充足的原奶供應將推動乳製品的擴張和消費,預計需求將會增加。 印度、中國和日本等國家是牛奶和乳製品的主要生產國,益生元被用於生產無糖、有質感的乳製品。 亞太地區益生元的供應量正在增加,益生元業務預計將在全球範圍內增長。
豬流感和豬流行性腹瀉病毒(PEDv)等危險動物疾病的發病率不斷上升,增加了對動物飼料原料的需求,以防止危險病原體附著在腸道細胞中。預計歐洲將呈現最高的增長率預測期內全球益生元市場。 這正在增加該地區的市場收入。 此外,嬰兒配方奶粉中益生元替代母乳正在推動市場擴張。
2023 年 5 月,嘉吉將在華盛頓州設立新工廠,擴大其零售飼料業務。 格蘭傑的新零售飼料設施將擴大其現有的零售飼料足跡,使其能夠更好地服務於太平洋西北地區的零售和農場和牧場客戶。
2023 年 4 月,雅培宣布完成對 Cardioangio Systems, Inc. (CSI) 的收購,這是一家醫療器械公司,擁有用於治療外周動脈和冠狀動脈疾病的創新斑塊切除系統。
2022 年 11 月,嘉吉與位於肯塔基州歐文斯伯勒的第五代家族大豆加工和精煉廠歐文斯伯勒穀物公司宣布嘉吉已達成最終協議。
According to Stratistics MRC, the Global Prebiotics Market is accounted for $8.2 billion in 2023 and is expected to reach $24.6 billion by 2030 growing at a CAGR of 16.9% during the forecast period. Prebiotics are soluble fibers that cannot be digested and help the growth of beneficial bacteria in the large intestine. Prebiotics have a number of health advantages, including improving immune and digestive function and controlling blood sugar and cholesterol levels in people. Asparagus, chicory root, garlic, onion, and other foods are high in prebiotics. Prebiotics have many uses, including improving the texture of food and beverages and giving them a sweeter taste without adding any sugar. Furthermore, prebiotics aid in boosting milk production and enhancing dairy animals' growth.
According to the National Dairy Development Board (NDDB), the demand in India is projected to reach 266.5 million metric tonnes for dairy products by 2030.
The prebiotic market is experiencing revenue growth as a result of rising prebiotic consumption for gut health. Prebiotic ingredients are used by numerous end-use industries to create sugar substitutes and low-calorie foods. Widely used in the food and beverage industry, FOS Inulin, Mannan-Oligosaccharide (MOS), and Galacto-Oligosaccharide (GOS) are gentle on the digestive system, encourage the growth of beneficial bacteria in the gut, and enhance gut health. Prebiotics promote the development of beneficial bacteria in the gut by acting as fertilizers. Many fruits and vegetables contain them, especially those that have fiber and resistant starch, which are examples of complex carbohydrates.
The decline in consumer awareness of the health advantages of prebiotic products is limiting market revenue growth. The food and beverage industry's limited selection of prebiotic products and the general lack of knowledge about the inclusion of prebiotic ingredients in food and beverage products are contributing factors. Additionally, consumers' ignorance of the advantages of prebiotic products and the lack of effective marketing strategies are both limiting market growth.
Prebiotics and other plant-based oligosaccharides are expected to become more popular as a result of growing consumer demand for food and drink products with lower sugar and fat contents without compromising taste or texture. The market is anticipated to grow even more as obesity rates rise. Demand for prebiotics is also anticipated to increase over the forecast period due to their ability to boost the growth of probiotics and other colon bacteria as well as enhance gastrointestinal and immune system functions.
A significant factor impeding the growth of the global prebiotics market is the side effects of taking prebiotics in excess, which include diarrhea, gastroesophageal reflux, and abdominal pain. Another factor that is anticipated to impede this market's growth over the forecast period is fluctuating raw material prices.
Due to consumers' preference for immune system-boosting supplements, demand for prebiotic supplements increased during COVID-19. Food, drinks, and dairy products are in higher demand during quarantine because they are readily available in all stores. However, the prebiotic's sales have suffered as a result of the logistical networks' disruption.
During the forecast period, the food and beverage segment held the largest share. The significant market share of this sector is primarily attributable to consumers' growing awareness of their health and the rising demand for prebiotic food additives. Additionally, the segment's growth is also being fueled by people's propensity for leading healthy, active lifestyles, rising investments in the development of new products in the food and beverage sector, and awareness of health benefits.
Due to the increasing usage of galactooligosaccharides (GOS), this segment is anticipated to hold significant growth potential in the near future. Furthermore, it has numerous health benefits, including improvement in bone mineralization by stimulating calcium absorption, prevention of colon cancer, growth of bifidobacteria, and replacement of human milk oligosaccharides.
The largest market share for prebiotics is expected to be held by Asia-Pacific. One of the primary factors influencing the development of the Asia-Pacific market is the presence of well-known leaders in the region. Due to the area's large population and abundant local milk supply, which are fostering the expansion and consumption of dairy products there, demand is anticipated to rise. Prebiotics are used in the production of dairy products that are sugar-free and have a better textural consistency in nations like India, China, and Japan, which are major producers of milk and milk products. The prebiotics business is expected to grow globally as a result of prebiotics' increasing utility in Asia-Pacific.
Due to the rising incidence of dangerous animal diseases like swine flu and porcine epidemic diarrhea virus (PEDv), which has fueled demand for animal feed ingredients to prevent dangerous pathogen adhesion in intestinal cells, Europe is predicted to experience the highest growth rate in the global prebiotics market during the forecast period. This is helping to boost market revenue in the region. Additionally, the substitution of prebiotics for breast milk in infant formulas is accelerating market expansion.
Some of the key players profiled in the Prebiotics Market include Abbott Laboratories, BENEO GmbH, Bright Food (Group) Corp. Ltd., Cargill Inc. ,Cosucra Groupe, Warcoing SA, FrieslandCampina, Jarrow Formulas, Inc., Kraft Foods Group, Inc., Parmalat S.p.A, Roquette Freres, Royal Cosun, The Kraft Heinz Company and Yakult Honsha Co., Ltd.
In May 2023, Cargill expands retail feed operation with plans for new facility in Washington state to service region's customers. The new Granger retail feed facility expands their existing retail feed footprint, enabling to better service the retail customers and their farm and ranch customers in the Pacific Northwestern region.
In April 2023, Abbott announced it has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
In November 2022, Cargill and Owensboro Grain Company, a fifth-generation family-owned soybean processing facility and refinery located in Owensboro, Ky., announced that they have entered into a definitive agreement where Cargill.
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.